Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

Professor Zeng Zexian's team from the Center for Quantitative Biology at the Peking University Academy for Advanced Interdisciplinary Studies, in collaboration with the Peking University-Tsinghua ...

When your social media account starts spewing out nonsensical or threatening status updates, it's safe to assume that it has ...

According to a recent study, researchers are developing nanotechnology that can improve the treatment of one of the most ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

T cell engagers are an exciting area of immunotherapy that remains in the early innings of development. We believe gamma-delta T cells offer unique properties, including tissue residence, phagocytosis ...

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...